<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Food and Drug Administration Center for Drug Evaluation and Research United States Department of Health and Human Services Rintatolimod Chronic Fatigue Syndrome Advisory Committee Drug development Off-label use Pharmacology Pharmaceutical sciences Clinical research |
Add to Reading List |
Microsoft Word[removed]Stakeholder Teleconference Transcript.doc